Fierce Healthcare August 1, 2024
Paige Minemyer

Updated at 2:30 p.m. ET on Aug. 1

Cigna CEO David Cordani mounted a defense of pharmacy benefit managers during the company’s earnings call on Thursday morning as regulators and critics turn up the heat on the industry.

Cigna owns Express Scripts, which along with CVS’ Caremark and UnitedHealth Group’s Optum Rx, dominate the PBM space. Cordani said that pharmacological innovation is a “key force of change in healthcare,” but as new and more sophisticated drugs come to market, they also come with a price.

Last year, the median yearly cost for new therapies grew by $300,000, or 25%, compared to 2022, Cordani said. However, Express Scripts was able to keep cost-sharing “relatively flat on average,” demonstrating the significant role...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
Centene expands board with former Prudential finance chief
Revenue Cycle and Payer News – February 26, 2025
Humana Taps Thyme Care for Value-Based Oncology Care
Trump's new price transparency executive order: 6 notes for payers
Most doctors fear insurers using AI to deny coverage

Share This Article